Secondary bladder cancer after upper tract urothelial carcinoma in the US population

BJU International

Volumn 110, Issue 9, 2012, Pages 1325-1329

  Kates, Max ^a   Badalato, Gina M ^a   Gupta, Mantu ^a   McKiernan, James M ^a  

^a New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

bladder cancer; bladder recurrence; Epidemiology and End Results (SEER); Surveillance; upper tract urothelial cancer; ureteroscopy

Indexed keywords

AGED; ARTICLE; BLADDER CARCINOGENESIS; BLADDER METASTASIS; CANCER MORTALITY; CANCER REGISTRY; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; RECURRENCE RISK; SECOND CANCER; TRANSITIONAL CELL CARCINOMA; TUMOR VOLUME; UNITED STATES; URETER TUMOR;

AGED; CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; REGISTRIES; SEER PROGRAM; TUMOR BURDEN; UNITED STATES; URETERAL NEOPLASMS; URINARY BLADDER NEOPLASMS;

EID: 84867740280     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.11108.x     Document Type: Article

References (24)

1. Oosterlinck W, Solsona E, van der Meijden AP, et al,. EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma. Eur Urol 2004; 46: 147-54
2. Painter DJ, Timoney AG, Denton K, et al,. The modern management of upper urinary tract urothelial cancer: tumour diagnosis, grading and staging. BJU Int 2007; 99: 973-7
3. Johnson GB, Grasso M,. Ureteroscopic management of upper urinary tract transitional cell carcinoma. Curr Opin Urol 2005; 15: 89-93
4. Soderdahl DW, Fabrizio MD, Rahman NU, Jarrett TW, Bagley DH,. Endoscopic treatment of upper tract transitional cell carcinoma. Urol Oncol 2005; 23: 114-22
5. Bariol SV, Stewart GD, McNeill SA, Tolley DA,. Oncological control following laparoscopic nephroureterectomy: 7-year outcome. J Urol 2007; 172: 1805-8
6. Novara G, De Marco V, Dalpiaz O, et al,. Independent predictors of metachronous bladder transitional cell carcinoma (TCC) after nephroureterectomy for TCC of the upper urinary tract. BJU Int 2008; 101: 1368-74
7. Hankey BF, Feuer EJ, Clegg LX, et al,. Cancer surveillance series: interpreting trends in prostate cancer-part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. J Natl Cancer Inst 1999; 91: 1017-24
8. Matsui Y, Utsunomiya N, Ichioka K, et al,. Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract. Urology 2005; 65: 279-83
9. Hisataki T, Miyao N, Masumori N, et al,. Risk factors for the development of bladder cancer after upper tract urothelial cancer. Urology 2000; 55: 663-7
10. Ishikawa S, Abe T, Shinohara N, et al,. Impact of diagnostic ureteroscopy on intravesical recurrence and survival in patients with urothelial carcinoma of the upper urinary tract. J Urol 2010; 184: 883-7
11. Kang CH, Yu TJ, Hsieh HH, et al,. The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract. Cancer 2003; 98: 1620-6
12. Mullerad M, Russo P, Golijanin D, et al,. Bladder cancer as a prognostic factor for upper tract transitional cell carcinoma. J Urol 2004; 172: 2177-81
13. Wright JL, Hotaling J, Porter MP,. Predictors of upper tract urothelial cell carcinoma after primary bladder cancer: a population based analysis. J Urol 2009; 181: 1035-9; discussion 1039
14. Terakawa T, Miyake H, Muramaki M, et al,. Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract. Urology 2008; 71: 123-7
15. Holmang S, Johansson SL,. Urothelial carcinoma of the upper urinary tract: comparison between the WHO/ISUP 1998 consensus classification and WHO 1999 classification system. Urology 2005; 66: 274-8
16. Browne RF, Meehan CP, Colville J, et al,. Transitional cell carcinoma of the upper urinary tract: spectrum of imaging findings. Radiographics 2005; 25: 1609-27
17. Delomez J, Claudon M, Darmaillacq C, et al,. [Imaging of upper urinary tract tumors]. J Radiol 2002; 83: 825-38, discussion 839-41
18. Wang LJ, Wong YC, Huang CC, et al,. Multidetector computerized tomography urography is more accurate than excretory urography for diagnosing transitional cell carcinoma of the upper urinary tract in adults with hematuria. J Urol 2010; 183: 48-55
19. McCoy JG, Honda H, Reznicek M, et al,. Computerized tomography for detection and staging of localized and pathologically defined upper tract urothelial tumors. J Urol 1991; 146: 1500-3
20. Planz B, George R, Adam G, et al,. Computed tomography for detection and staging of transitional cell carcinoma of the upper urinary tract. Eur Urol 1995; 27: 146-50
21. Kume H, Teramoto S, Tomita K, et al,. Bladder recurrence of upper urinary tract cancer after laparoscopic surgery. J Surg Oncol 2006; 93: 318-22
22. Koda S, Mita K, Shigeta M, et al,. Risk factors for intravesical recurrence following urothelial carcinoma of the upper urinary tract: no relationship to the mode of surgery. Jpn J Clin Oncol 2007; 37: 296-301
23. Bariol SV, Stewart GD, McNeill SA, et al,. Oncological control following laparoscopic nephroureterectomy: 7-year outcome. J Urol 2004; 172: 1805-8
24. Rassweiler JJ, Schulze M, Marrero R, et al,. Laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: is it better than open surgery? Eur Urol 2004; 46: 690-7